[go: up one dir, main page]

CY2247B1 - Indole derivative - Google Patents

Indole derivative

Info

Publication number
CY2247B1
CY2247B1 CY0100039A CY0100039A CY2247B1 CY 2247 B1 CY2247 B1 CY 2247B1 CY 0100039 A CY0100039 A CY 0100039A CY 0100039 A CY0100039 A CY 0100039A CY 2247 B1 CY2247 B1 CY 2247B1
Authority
CY
Cyprus
Prior art keywords
lower alkoxy
alkoxy
alkoxycarbonyl
indole derivative
carboxy
Prior art date
Application number
CY0100039A
Other languages
English (en)
Inventor
Shiro Kato
Hiroshi Harada
Yoshimi Hirokawa
Naoyuki Yoshida
Hitoshi Kawashima
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of CY2247B1 publication Critical patent/CY2247B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CY0100039A 1994-11-29 2001-11-20 Indole derivative CY2247B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP06321402 1994-11-29

Publications (1)

Publication Number Publication Date
CY2247B1 true CY2247B1 (en) 2003-07-04

Family

ID=18132155

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0100039A CY2247B1 (en) 1994-11-29 2001-11-20 Indole derivative

Country Status (29)

Country Link
US (1) US5817689A (xx)
EP (1) EP0801059B1 (xx)
JP (1) JP3100165B2 (xx)
KR (1) KR100388747B1 (xx)
CN (1) CN1070477C (xx)
AT (1) ATE202559T1 (xx)
AU (1) AU688165B2 (xx)
BR (1) BR9509827A (xx)
CA (1) CA2206307A1 (xx)
CY (1) CY2247B1 (xx)
CZ (1) CZ290871B6 (xx)
DE (1) DE69521529T2 (xx)
DK (1) DK0801059T3 (xx)
ES (1) ES2159648T3 (xx)
FI (1) FI972275A0 (xx)
GR (1) GR3036148T3 (xx)
HK (1) HK1003886A1 (xx)
HU (1) HUT77308A (xx)
IL (1) IL116178A (xx)
NO (1) NO309648B1 (xx)
NZ (1) NZ295749A (xx)
PL (1) PL181963B1 (xx)
PT (1) PT801059E (xx)
RO (1) RO118426B1 (xx)
RU (1) RU2137759C1 (xx)
SK (1) SK281865B6 (xx)
TW (1) TW349091B (xx)
WO (1) WO1996016938A1 (xx)
ZA (1) ZA9510130B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20010580A1 (es) * 1999-09-03 2001-05-25 Takeda Chemical Industries Ltd Composicion farmaceutica para tratar la diabetes
WO2001040182A2 (en) * 1999-11-30 2001-06-07 Dainippon Pharmaceutical Co., Ltd. Solid pharmaceutical preparation
US6458824B1 (en) * 1999-11-30 2002-10-01 Dainippon Pharmaceutical Co., Ltd. Solid preparation
JP2004331500A (ja) * 2001-02-16 2004-11-25 Dainippon Pharmaceut Co Ltd 血中濃度制御製剤
EP2335700A1 (en) * 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
AU2003225277A1 (en) * 2002-05-02 2003-11-17 Robert Harris Lipid removal from the body
CA2488699A1 (en) * 2002-06-12 2003-12-24 Sumitomo Pharmaceuticals Co., Ltd. Indole, indazole, and benzazole derivative
SI1599468T1 (sl) * 2003-01-14 2008-02-29 Arena Pharm Inc 1,2,3-trisubstituirani arilni in heteroarilni derivati kot modulatorji metabolizma ter profilaksa in zdravljenje motenj v zvezi z njim, kot diabetesain hiperglikemije
AU2004205642C1 (en) * 2003-01-14 2012-01-12 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US7098231B2 (en) 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
WO2004089936A1 (ja) * 2003-04-10 2004-10-21 Dainippon Pharmaceutical Co., Ltd. ヘテロアリールスルホン酸アニリド誘導体及びそれを含有する医薬組成物
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
CA2553879C (en) 2004-02-20 2011-02-22 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
EP1915378A4 (en) * 2005-08-12 2009-07-22 Boehringer Ingelheim Int VIRUS POLYMERASE INHIBITORS
SG188548A1 (en) 2010-09-22 2013-04-30 Arena Pharm Inc Modulators of the gpr119 receptor and the treatment of disorders related thereto
ES2394349B1 (es) 2012-08-29 2013-11-04 Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii Uso de agonistas selectivos de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar
JP6660668B2 (ja) * 2014-06-24 2020-03-11 花王株式会社 Ｕｃｐ−１発現促進剤
US10758519B2 (en) 2014-06-24 2020-09-01 Kao Corporation UCP-1 expression promoter
WO2015199097A1 (ja) * 2014-06-24 2015-12-30 花王株式会社 Ｕｃｐ－１発現促進剤
NZ734220A (en) 2015-01-06 2022-01-28 Arena Pharm Inc Methods of treating conditions related to the s1p1 receptor
KR102603199B1 (ko) 2015-06-22 2023-11-16 아레나 파마슈티칼스, 인크. Ｓ1ｐ1 수용체-관련 장애에서의 사용을 위한 (ｒ)-2-(7-(4-시클로펜틸-3-(트리플루오로메틸)벤질옥시)-1,2,3,4-테트라히드로시클로-펜타[ｂ]인돌-3-일)아세트산 (화합물 1)의 결정성 ｌ-아르기닌 염
BR112020024762A2 (pt) 2018-06-06 2021-03-23 Arena Pharmaceuticals, Inc. métodos de tratamento de condições relacionadas ao receptor s1p1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB861428A (en) * 1958-07-14 1961-02-22 Searle & Co Improvements in or relating to indole derivatives
US4055658A (en) * 1976-05-17 1977-10-25 Mead Johnson & Company Cyanomethylphenethanolamines
US4338333A (en) * 1979-06-16 1982-07-06 Beecham Group Limited Ethanamine derivatives their preparation and use in pharmaceutical compositions
FR2541999B1 (fr) * 1983-03-04 1986-09-19 Bristol Myers Co Phenethanolamines et leurs utilisations
JPH06345731A (ja) * 1992-04-28 1994-12-20 Dainippon Pharmaceut Co Ltd ２−〔２−（インドール−３−イル）エチルアミノ〕−１−フェニルエタノール誘導体
JPH0634531A (ja) * 1992-07-14 1994-02-08 Yokogawa Electric Corp 赤外線水分計

Also Published As

Publication number Publication date
HK1003886A1 (en) 1998-11-13
FI972275L (fi) 1997-05-29
IL116178A (en) 2000-07-26
NZ295749A (en) 1998-05-27
GR3036148T3 (en) 2001-09-28
CN1070477C (zh) 2001-09-05
CZ290871B6 (cs) 2002-11-13
BR9509827A (pt) 1997-09-30
MX9703858A (es) 1997-09-30
IL116178A0 (en) 1996-01-31
RO118426B1 (ro) 2003-05-30
CA2206307A1 (en) 1996-06-06
US5817689A (en) 1998-10-06
SK65697A3 (en) 1998-01-14
EP0801059A1 (en) 1997-10-15
DK0801059T3 (da) 2001-09-24
CN1174549A (zh) 1998-02-25
DE69521529D1 (de) 2001-08-02
KR100388747B1 (ko) 2004-03-30
JP3100165B2 (ja) 2000-10-16
ATE202559T1 (de) 2001-07-15
AU688165B2 (en) 1998-03-05
EP0801059B1 (en) 2001-06-27
ES2159648T3 (es) 2001-10-16
FI972275A0 (fi) 1997-05-29
PL181963B1 (pl) 2001-10-31
EP0801059A4 (en) 1998-01-21
RU2137759C1 (ru) 1999-09-20
NO309648B1 (no) 2001-03-05
HUT77308A (hu) 1998-03-30
NO972427D0 (no) 1997-05-28
PL320461A1 (en) 1997-09-29
DE69521529T2 (de) 2001-10-11
CZ165597A3 (en) 1997-11-12
NO972427L (no) 1997-07-28
SK281865B6 (sk) 2001-08-06
AU3936695A (en) 1996-06-19
TW349091B (en) 1999-01-01
WO1996016938A1 (en) 1996-06-06
ZA9510130B (en) 1996-06-11
PT801059E (pt) 2001-10-30

Similar Documents

Publication Publication Date Title
CY2247B1 (en) Indole derivative
AU573018B2 (en) 11-substituted 16-phenoxy prostatrienoic acid derivatives
HU9302530D0 (en) Herbicidal pyridinesulphonamide compounds
HK1012341A1 (en) Pyrrolocarbazole
IL118367A0 (en) Heteroaroyl derivatives
DE69222459D1 (de) Thiazolidindionderivate, ihre Herstellung und Anwendung
DE69810960D1 (de) 2-phenoxyanilin-derivate
ZA899366B (en) Substituted imidazole derivatives and their preparation and use
EP0889033A4 (xx)
EP1034783A4 (en) AMIDE DERIVATIVES
AU6063298A (en) Benzamide derivative, anti-ulcer drug, and antibacterial drug
AU5601190A (en) Carboxamide derivatives
EP1203763A3 (de) Beta-Hydroxyalkylamide, Verfahren zu ihrer Herstellung und deren Verwendung
GR3025405T3 (en) Bicyclic oxazole and thiazole substituted ethers
ZA812541B (en) Benzothiazole derivatives and salts thereof,processes for their preparation,and their use as sweetening agents
AU650630B2 (en) Novel benzoxazolone compounds and the use thereof as microbicides
GR3022628T3 (en) Heterocyclic derivatives of alkoxyacrylates with fungicidal activity
GB8700748D0 (en) Preparation of heterocyclic compounds
TH19060A (th) อนุพันธุ์คาร์โบสไตริล วิธีการเตรียมสารดังกล่าวและตัวยับยั้งแมทตริกซ์เมทัลโลโปรตีเนสภายนอกเซล